What is the differential diagnosis for heavy bleeding after initiating hormonal contraception?

Differential Diagnosis for Heavy Bleeding After Starting Birth Control

Heavy bleeding after initiating hormonal contraception is most commonly a benign side effect expected during the first 3-6 months of use, but you must systematically exclude pregnancy complications, medication interactions, sexually transmitted infections, and new pathologic uterine conditions before attributing it to the contraceptive method itself. 1

Primary Differential Considerations

1. Expected Method-Related Bleeding (Most Common)

• Unscheduled bleeding is the normal physiologic response to hormonal contraception during the initial 3-6 months, particularly with progestin-only methods (pills, DMPA injections, implants, LNG-IUDs) and extended/continuous combined hormonal contraceptives 1
• This bleeding is generally not harmful and typically decreases with continued use 1

2. Pregnancy-Related Causes (Must Rule Out First)

• Any abnormal bleeding in reproductive-age women using contraception should be considered pregnancy-related until proven otherwise 2
• Specific pregnancy complications to consider:
  • Threatened, incomplete, or missed abortion
  • Ectopic pregnancy
  • Trophoblastic disease
  • Placental polyp
  • Subinvolution of placental site 2
• This is especially critical if there has been inconsistent contraceptive use or method failure 1

3. Medication Interactions and Compliance Issues

• Poor compliance or inconsistent use is a frequent cause of breakthrough bleeding, particularly with oral contraceptives 3
• Drug interactions that reduce contraceptive hormone levels (certain anticonvulsants, antibiotics, St. John's Wort) 1
• Concurrent medications: anticoagulants, digitalis, phenytoin 2

4. Infectious Causes

• Sexually transmitted infections (chlamydia, gonorrhea) 1
• Endometritis 2
• Pelvic inflammatory disease 1
• Severe vaginal infections 2
• Cervicitis 2

5. Structural/Pathologic Uterine Conditions

• New-onset structural abnormalities:
  • Endometrial or cervical polyps 1, 2
  • Uterine fibroids (leiomyomas), particularly submucous 2
  • Adenomyosis 2
  • Endometriosis 2
• Malignancies (especially in perimenopausal women):
  • Endometrial carcinoma
  • Cervical cancer
  • Vaginal or vulvar malignancies
  • Granulosa-theca cell ovarian tumors 2

6. Device-Related Issues (for IUD users)

• IUD displacement or malposition 1
• Foreign body reaction 2

7. Systemic Diseases

• Coagulopathies (particularly important in adolescents with heavy bleeding):
  • Von Willebrand disease (more common than typically recognized) 2
  • Other inherited bleeding disorders 4
  • Platelet dysfunction 2
• Thyroid disorders (hypothyroidism) 1, 2
• Hepatic disease (cirrhosis) 2

8. Iatrogenic/Method-Specific Causes

• Hypothalamic depressants 2
• The contraceptive device itself (particularly copper IUDs cause heavier bleeding as an expected side effect) 1

9. Traumatic Causes

• Vaginal lacerations or trauma 2
• Cervical erosion 2

Clinical Approach Algorithm

Step 1: Exclude Pregnancy

• Obtain pregnancy test if any possibility of conception, poor compliance, or clinical suspicion 1

Step 2: Assess Timing and Pattern

• If bleeding occurs within first 3-6 months of initiation and patient is otherwise well, this is likely expected method-related bleeding 1
• If bleeding develops after months of stable use, suspect new pathology 1

Step 3: Evaluate for Organic Causes

• History: Medication compliance, new medications, sexual history (STI risk), systemic symptoms, personal/family bleeding history 1, 3
• Physical examination: Pelvic exam to assess for cervical lesions, uterine size/tenderness, adnexal masses 3
• Laboratory evaluation:
  • Pregnancy test
  • STI testing (gonorrhea, chlamydia) 1
  • Complete blood count (if heavy bleeding)
  • Thyroid function tests 1
  • Coagulation studies if: adolescent with menorrhagia, personal/family bleeding history, failure of medical/surgical therapy, or ovulatory bleeding without anatomic lesion 2
• Imaging: Pelvic ultrasound to evaluate for structural abnormalities 4

Step 4: Treat Identified Pathology or Reassure

• If organic cause identified: treat condition or refer for specialized care 1
• If no pathology found and within first 3-6 months: provide reassurance and counseling about expected bleeding patterns 1

Critical Pitfalls to Avoid

• Never assume bleeding is benign without pregnancy testing in women of reproductive age with any possibility of conception 2
• Do not dismiss persistent bleeding beyond 3-6 months as normal without investigating for new pathology 1
• Screen for coagulopathies in adolescents presenting with heavy menstrual bleeding, as von Willebrand disease and other bleeding disorders are underdiagnosed 2
• Consider malignancy in perimenopausal/postmenopausal women with any abnormal bleeding 2
• Assess medication compliance before attributing bleeding to method failure, as inconsistent use is a common cause 3